Glenmark Pharmaceuticals Ltd.
| BSE: 532296 | Sector: Health care |
| NSE: GLENMARK | ISIN Code: INE935A01035 |
| BSE 00:00 | 15 Jan | 512.25 |
-8.20 (-1.58%) |
OPEN
520.70 |
HIGH
524.00 |
LOW
508.50 |
| NSE 00:00 | 15 Jan | 512.10 |
-8.30 (-1.59%) |
OPEN
521.90 |
HIGH
524.75 |
LOW
508.05 |
| OPEN | 520.70 |
| PREVIOUS CLOSE | 520.45 |
| VOLUME | 135041 |
| 52-Week high | 572.70 |
| 52-Week low | 168.00 |
| P/E | 9.49 |
| Mkt Cap.(Rs cr) | 14,456 |
| Buy Price | 512.25 |
| Buy Qty | 40.00 |
| Sell Price | 516.00 |
| Sell Qty | 30.00 |
Glenmark Pharmaceuticals Ltd. (GLENMARK) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sanofi India | 8336.25 | -0.86 | 8999.00 | 5900.05 | 19198.38 |
| Dr Lal Pathlabs | 2293.75 | -1.73 | 2454.20 | 1181.80 | 19116.11 |
| Natco Pharma | 917.05 | -2.16 | 995.05 | 450.00 | 16713.24 |
| Jubilant Life | 975.65 | -2.91 | 1012.85 | 230.00 | 15542.10 |
| Ajanta Pharma | 1746.95 | -1.07 | 1844.10 | 961.65 | 15119.85 |
| Max Healthcare | 159.95 | -0.71 | 167.25 | 101.65 | 14467.96 |
| Glenmark Pharma. | 512.25 | -1.58 | 572.70 | 168.00 | 14455.69 |
| Suven Pharma | 502.55 | -0.02 | 515.50 | 87.05 | 12794.92 |
| Fortis Health. | 166.00 | -3.29 | 182.00 | 113.20 | 12532.34 |
| P & G Health Ltd | 6801.65 | 0.23 | 7356.35 | 2927.80 | 11290.74 |
| Metropolis Healt | 2164.00 | -0.52 | 2321.00 | 993.20 | 11058.04 |
| Astrazeneca Phar | 4222.65 | -0.15 | 4970.00 | 1888.00 | 10556.62 |
| Narayana Hrudaya | 468.30 | -1.00 | 480.00 | 210.00 | 9570.18 |
| Granules India | 355.95 | -2.76 | 438.00 | 114.50 | 8816.88 |
| ERIS Lifescience | 624.50 | 1.45 | 630.00 | 341.05 | 8480.71 |
| Strides Pharma | 908.45 | -1.40 | 1000.00 | 271.00 | 8143.35 |
| Aster DM Health. | 162.20 | -0.34 | 180.50 | 78.50 | 8102.05 |
| J B Chem & Pharm | 1041.90 | 0.77 | 1150.00 | 434.90 | 8053.89 |
| Aarti Drugs | 707.50 | -1.20 | 1025.00 | 105.56 | 6593.90 |
| Wockhardt | 532.90 | 0.28 | 569.80 | 147.20 | 5903.47 |
Quick Links for Glenmark Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
